NCT02004860

Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis

Phase 3 : Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis on Adult Face

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 120 (actual)
• Sponsor: University Hospital, Rouen · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Seborrheic dermatitis is a chronic inflammatory dermatological disease, evolving by relapses, affecting mainly the face and scalp. It would be important to have a maintenance treatment for severe forms of seborrheic dermatitis witch is both effective and relatively well tolerated to reduce the frequency of relapses, prolong remissions obtained after attack treatment and reduce the use of topical steroids.

Conditions

• Severe Seborrheic Dermatitis

Interventions

Type	Name	Description
DRUG	Protopic (R)	Protopic® 0.1% ointment - 2 applications per week for 6 months
DRUG	Mycoster (R)	Mycoster 1% - 2 applications per week for 6 months

Timeline

• Start date: 2014-01-01
• Primary completion: 2017-10-01
• Completion: 2017-10-01
• First posted: 2013-12-09
• Last updated: 2018-05-29

Locations

1 site across 1 country: France